SEC Form 4 · accession 0001225208-19-005065
O-I Glass, Inc. /DE/ · OI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy M. Connors
Officer — President, O-I Asia Pacific
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000812074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (Direct)F1 | Mar 7, 2019 | A | 19,934 | $0.00 | A | 48,105 | D | |
| Common Stock (Direct)F2 | Mar 7, 2019 | A | 8,176 | $0.00 | A | 56,281 | D | |
| Common Stock (Direct) | Mar 7, 2019 | M | 300 | $15.05 | A | 56,581 | D | |
| Common Stock (Direct) | Mar 7, 2019 | S | 300 | $19.68 | D | 56,281 | D | |
| Common Stock (Direct)F3 | Mar 7, 2019 | S | 6,382 | $19.7449 | D | 49,899 | D | |
| Common Stock (Direct)F4 | Mar 7, 2019 | S | 7,104 | $19.6459 | D | 42,795 | D | |
| Common Stock (Direct)F5 | Mar 7, 2019 | S | 19,934 | $19.5215 | D | 22,861 | D | |
| Common Stock (Direct) | Mar 8, 2019 | M | 10,995 | $15.05 | A | 33,856 | D | |
| Common Stock (Direct)F6 | Mar 8, 2019 | S | 10,995 | $19.4184 | D | 22,861 | D | |
| Common Stock (Indirect) | holding | — | — | — | 900 | I | By 401k |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option 03/07/2016 $15.05F7 | $15.05 | Mar 7, 2019 | M | 300 | D | Mar 7, 2017 | Mar 7, 2023 | Common Stock (Direct) | 300 | 14,760 | D |
| Stock Option 03/07/2016 $15.05F7 | $15.05 | Mar 8, 2019 | M | 10,995 | D | Mar 7, 2017 | Mar 7, 2023 | Common Stock (Direct) | 10,995 | 3,765 | D |
Explanation of responses
- F1Certain restricted stock units granted for the 2016-2018 grant period vest in the form of common stock based upon the Issuer's performance against certain strategic objective goals. On March 7, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the strategic objective goals had been met, resulting in the vesting of these shares.
- F2The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $19.895, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.675, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.44 to $19.64, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.40 to $19.485, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F7The options become exercisable in annual 25% increments beginning on the first anniversary of the grant date, March 7, 2017.